Javier Cornago

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC study.

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC study.

Journal: British journal of haematology

Published: February 24, 2026

Morphofunctional parameters as predictors of autologous hematopoietic stem cell transplantation outcomes.

Morphofunctional parameters as predictors of autologous hematopoietic stem cell transplantation outcomes.

Journal: Frontiers in nutrition

Published: July 15, 2025

Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.

Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.

Journal: Molecular oncology

Published: May 16, 2025

Improved identification of T-ALL paediatric patients with low MRD but poor prognosis using a transcriptional signature.

Improved identification of T-ALL paediatric patients with low MRD but poor prognosis using a transcriptional signature.

Journal: British journal of haematology

Published: May 05, 2025

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Journal: Blood advances

Published: November 25, 2024

Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report.

Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report.

Journal: Biomedicines

Published: January 25, 2024

When the devil is in the details: Similarities and differences between WHO and ICC classifications of AML.

When the devil is in the details: Similarities and differences between WHO and ICC classifications of AML.

Journal: Leukemia research

Published: December 05, 2023

PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.

PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.

Journal: NPJ precision oncology

Published: October 18, 2023

Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin's Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient.

Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin's Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient.

Journal: Medicina (Kaunas, Lithuania)

Published: June 10, 2023

Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report.

Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report.

Journal: Medicina (Kaunas, Lithuania)

Published: May 10, 2023

The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.

The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.

Journal: Molecular carcinogenesis

Published: April 11, 2023

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.

Journal: British journal of haematology

Published: March 19, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026